Propofol infusion syndrome in patients with refractory status epilepticus: An 11-year clinical experience

Critical Care Medicine

Volumn 37, Issue 12, 2009, Pages 3024-3030

  Iyer, Vivek N ^a   Hoel, Rebecca ^a,b   Rabinstein, Alejandro A ^a  

^a MAYO CLINIC   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Intensive care unit; Mortality; Propofol infusion syndrome; Refractory status epilepticus

Indexed keywords

ADRENALIN; ANTICONVULSIVE AGENT; CALCIUM; FOSPHENYTOIN SODIUM; GLUCAGON; LORAZEPAM; MIDAZOLAM; NORADRENALIN; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; VALPROIC ACID; HYPNOTIC SEDATIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG WITHDRAWAL; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; SCHOOL CHILD; SEIZURE; TREATMENT DURATION; CASE REPORT; CRITICAL ILLNESS; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SYNDROME; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPOFOL; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; SYNDROME; TIME FACTORS;

EID: 73349137319     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b08ac7     Document Type: Article

References (35)

1. Bleck TP: Management approaches to prolonged seizures and status epilepticus. Epi-lepsia 1999, 40(Suppl 1):S59-S63; discussion S64-S56
2. Brown LA, Levin GM: Role of propofol in refractory status epilepticus. Ann Pharmaco-ther 1998; 32:1053-1059
3. Claassen J, Hirsch LJ, Emerson RG, et al: Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia 2002; 43: 146-153
4. Treiman DM, Meyers PD, Walton NY, et al: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Ned 1998; 339:792-798
5. Parke TJ, Stevens JE, Rice AS, et al: Metabolic acidosis and fatal myocardial failure after propofol infusion in children: Five case reports. BMJ Clin Res Ed 1992; 305:613-616
6. Cremer OL, Moons KG, Bouman EA, et al: Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357:117-118
7. Bray RJ: Propofol-infusion syndrome in children. Lancet 1999; 353:2074-2075
8. Borgeat A, Wilder-Smith OH, Jallon P, Suter PM: Propofol in the management of refractory status epilepticus: A case report. Intensive care medicine 1994; 20:148-149
9. Gaggero G, Ravussin P, Borgeat A, et al: Use of propofol in intracranial surgery in 83 consecutive patients. Neuro Chirurgie 1994; 40: 127-131
10. Parviainen I, Kalviainen R, Ruokonen E: Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. Neurol Res 2007; 29:667-671
11. Parviainen I, Uusaro A, Kalviainen R, et al: Propofol in the treatment of refractory status epilepticus. Intensive Care Med 2006; 32: 1075-1079
12. Rossetti AO, Reichhart MD, Schaller MD, et al: Propofol treatment of refractory status epilepticus: A study of 31 episodes. Epilepsia 2004; 45:757-763
13. Stecker MM, Kramer TH, Raps EC, et al: Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998; 39:18-26
14. Wood PR, Browne GP, Pugh S: Propofol infusion for the treatment of status epilepticus. Lancet 1988; 1:480-481
15. Yanny HF, Christmas D: Propofol infusions for status epilepticus. Anaesthesia 1988, 43: 514
16. Zarovnaya EL, Jobst BC, Harris BT: Propofol-associated fatal myocardial failure and rhab-domyolysis in an adult with status epilepti-cus. Epilepsia 2007; 48:1002-1006
17. Kam PC, Cardone D: Propofol infusion syndrome. Anaesthesia 2007; 62:690-701
18. Fong JJ, Sylvia L, Ruthazer R, et al: Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med 2008; 36:2281-2287
19. Fodale V, La Monaca E: Propofol infusion syndrome: An overview of a perplexing disease. Drug Saf 2008; 31:293-303
20. Prasad A, Worrall BB, Bertram EH, et al: Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001; 42:380-386
21. Rasmussen PA, Yang Y, Rutecki PA: Propofol inhibits epileptiform activity in rat hip-pocampal slices. Epilepsy Res 1996; 25: 169-175
22. Bray RJ: Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8:491-499
23. Westhout FD, Muhonen MG, Nwagwu CI: Early propofol infusion syndrome following cerebral angiographic embolization for giant aneurysm repair: Case report. J Neurosurg 2007, 106(2 Suppl):139-142
24. Chukwuemeka A, Ko R, Ralph-Edwards A: Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anaesth Intensive Care 2006; 34:651-655
25. Cravens GT, Packer DL, Johnson ME: Incidence of propofol infusion syndrome during noninvasive radiofrequency ablation for atrial flutter or fibrillation. Anesthesiology 2007; 106:1134-1138
26. Haase R, Sauer H, Eichler G: Lactic acidosis following short-term propofol infusion may be an early warning of propofol infusion syndrome. J Neurosurg Anesthesiol 2005; 17: 122-123
27. Pulsford AH: Comment: propofol infusion syndrome in critically ill patients. Ann Phar-macother 2003, 37:594; author reply 594-595
28. Papaioannou V, Dragoumanis C, Theodorou V, et al: The propofol infusion "syndrome" in intensive care unit: From pathophysiology to prophylaxis and treatment. Acta Anaesthe-siol Belg 2008; 59:79-86
29. Karakitsos D, Poularas J, Kalogeromitros A, et al: The propofol infusion syndrome treated with haemofiltration: Is there a time for genetic screening? Acta Anaesthesiol Scand 2007; 51:644-645
30. Kim DH, Kweon TD, Nam SB, et al: Effects of target concentration infusion of propofol and tracheal intubation on QTc interval. Anaesthesia 2008; 63:1061-1064
31. Saarnivaara L, Klemola UM, Lindgren L, et al: QT interval of the ECG, heart rate and arterial pressure using propofol, methohexi-tal or midazolam for induction of anaesthesia. Acta Anaesthesiol Scand 1990; 34: 276-281
32. Saarnivaara L, Hiller A, Oikkonen M: QT interval, heart rate and arterial pressures using propofol, thiopentone or methohexi-tone for induction of anaesthesia in children. Acta Anaesthesiol Scand 1993; 37: 419-423
33. Paventi S, Santevecchi A, Ranieri R: Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol 2001; 67:637-640
34. Kleinsasser A, Kuenszberg E, Loeckinger A, et al: Sevoflurane, but not propofol, significantly prolongs the Q-T interval. Anesth Analg 2000; 90:25-27
35. Michaloudis DG, Kanakoudis FS, Petrou AM, et al: The effects of midazolam or propofol followed by suxamethonium on the QT interval in humans. Eur J Anaesthesiol 1996; 13: 364-368